Characterization of a soluble form of neutral endopeptidase-24.11 (EC 3.4.24.11) in human serum: Enhancement of its activity in serum of underground miners exposed to Goal dust particles

European Journal of Clinical Investigation

Volumn 26, Issue 11, 1996, Pages 1011-1017

  Soleilhac, J M ^a   Lafuma, C ^b   Porcher, J M ^c   Auburtin, G ^c   Roques, B P ^a  

^a Laboratoire de Pharmacochimie   (France)

^b INSERM   (France)

^c INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

Author keywords

Coal mining; Environmental pollutants; Inflammation; Membrane metalloendopeptidase; Serum proteins; 125I RB104

Indexed keywords

4 [(1 BENZYL 3 HYDROXYAMINO 3 OXOPROPYL)AMINO] 2 (4 HYDROXY 3 IODOBENZYL) 4 OXOBUTANOIC ACID; BESTATIN; CAPTOPRIL; ENZYME INHIBITOR; METALLOPROTEINASE; RETROTHIORPHAN; THIORPHAN; UNCLASSIFIED DRUG;

ARTICLE; COAL MINING; DUST EXPOSURE; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; INFLAMMATION; LUNG INJURY; POLLUTION; PRIORITY JOURNAL;

EID: 0029960704     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.2420580.x     Document Type: Article

References (31)

1. Roques BP, Noble F, Daugé V, Fournié-Zaluski MC, Beaumont A. Neutral endopeptidase 24.11. Structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 1993; 45:87-147.
2. Malfroy B, Swerts JP, Guyon A, Roques BP, Schwartz JC. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 1978;276:523-6.
3. Kenny AJ, Stephenson SL. Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptides. FEBS Lett 1988; 232:1-8.
4. Fagny C, Michel A, Léonard I, Berkenboom G, Fontaine J, Deschodt-Lanckman M. In vitro degradation of endothelin-1 by endopeptidase-24.11 (enkephalinase). Peptides 1991;12:773-8.
5. Borson DB. Roles of neutral endopeptidase in airways. Am J Physiol 1911;260:L212-25.
6. LeTarte M, Vera S, Tran R, Addis JB et al. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J Exp Med 1988;168:1247-53.
7. Connelly JC, Skidgel RA, Schulz WW, Johnson AR, Erdos EG. Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc Natl Acad Sci USA 1985;82:8737-41.
8. Painter RG, Dukes R, Sullivan J, Carter R, Erdös EG, Johnson AR. Function of neutral endopeptidase on the cell membrane of human neutrophils. J Biol Chem 1988;263:9456-61.
9. Spillantini MG, Sicuteri F, Salmon S, Malfroy B. Characterization of endopeptidase 3.4.24.11 activity in human plasma and cerebrospinal fluid. Biochem Pharmacol 1990;39:1353-6.
10. Appelboom T, Maertelaer VD, Prez HD, Hauzeur J, Deschodt-Lanckman M. Enkephalinase: a physiologic neuroimmunomodulator detected in the synovial fluid. Arthritis Rheum 1991;34:1048-51.
11. Almenoff J, Teirstein AS, Thornton JC, Orlowski M. Identification of a thermolyisn-like metalloendopeptidase in serum: activity in normal subjects and in patients with sarcoidosis. J Lab Clin Med 1984;103:420-31.
12. Johnson AR, Coalson JJ, Ashton J, Larumbide M, Erdos EG. Neutral endopeptidase in serum samples from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:1262-7.
13. Deschodt-Lanckman M, Michaux F, de Prez E, Abramowicz D, Van-Herweghen JL, Goldman M. Increased serum levels of endopeptidase 24.11 ('enkephalinase') in patients with end-stage renal failure. Life Sci 1989;45:133-41.
14. Nortier J, Abramovicz D, Najdovski T et al. Urinary endopeptidase 24.11 as a new marker of proximal tubular injury. Preliminary study in kidney transplant recipitents. Contrib Nephrol 1993;101:169-76.
15. Porcher JM, Lafuma C, Nabout REI et al. Biological markers as indicators of exposure and pneumoconiotic risk: prospective study. Int Arch Occup Environ Health 1993;65:S209-13.
16. 125I]RB104, a new potent inhibitor of neutral endopeptidase-24.11 and its use in detecting nanogram quantities of the enzymes by 'inhibitor gel electrophoresis'. Proc Natl Acad Sci USA 1992;89:6388-92.
17. Roques BP, Lucas-Soroca E, Chaillet P, Costentin J, Fournié-Zaluski MC. Complete differentiation between 'enkephalinase' and angiotensin converting enzyme inhibition by retro-thiorphan. Proc Natl Acad Sci 1983;80:3178-82.
18. Waksman G, Bouboutou R, Devin J et al. 'In vitro' and 'in vivo' effects of kelatorphan or enkephalin metabolism in rodent brain. Eur J Pharmacol 1985;117:233-43.
19. Vogel Z, Alstein M. The absorption of enkephalin to porous polystyrene beads: a simple assay for enkephalin hydrolysis. FEBS Lett 1977;80:332-6.
20. Bieth J, Spiess B, Wermuth J. The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochem Med 1974;11:350-7.
21. Boucheix C, Perrot JY, Mirshahi M et al. A new set of monoclonal antibodies against acute lymphoblastic leukemia. Leukemia Res 1985;9:597-604.
22. Aubry M, Bertelot A, Beaumont A, Roques BP, Crine P. The use of a monoclonal antibody for the rapid purification of kidney neutral endopeptidase ('enkephalinase') solublilized in octyl glucoside. Biochem Cell Biol 1987;65:398-404.
23. Soleilhac JM, Lucas E. Beaumont A et al. A 94 Kdalton protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium. Mol Pharmacol 1992;41:609-14.
24. 1H NMR configurational correlation for retro-inverso dipeptides: application to the determination of the absolute configuration of 'enkephalinase' inhibitors. Relationships between stereochemistry and enzyme recognition. J Med Chem 1986;29:751-7.
25. Nadel JA. Neutral endopeptidase modulation of neurogenic inflammation in airways. Eur Respir J 1990;3(suppl 12):645s-51s.
26. Nadel JA. Membrane-bound peptidases: endocrine, paracrine, and autocrine effects. Am J Respir Cell Mol Biol 1992;7:469-70.
27. Zimmerman GA, Renzetti AD, Hill HR. Functional and metabolic activity of granulocytes from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1983;127:290-300.
28. Beaudoin AR, Grondin G. Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena. Biochim Biophys Acta 1991;1071:203-19.
29. Komada Y, Peiper S, Tarnowski B, Melvin S, Kamiya H, Sakurai M. Shedding of the common acute lymphoblastic leukemia antigen (CALLA) by lymphoblastoid cell lines. Leukemia Res 1986;10:665-70.
30. Sutherland R, Smart J, Niaudet P, Greaves M. Acute lymphoblastic leukaemia associated antigen-II. Isolation and partial characterization. Leukemia Res 1978;2:115-26.
31. Beldent V, Michaud A, Wei L, Chauvet MT, Corvol P. Proteolytic release of human angiotensin-converting enzyme localization of the cleavage site. J Biol Chem 1993;35:26428-34.